RTW INVESTMENTS, LP Q4 2021 Filing
Filed February 14, 2022
Portfolio Value
$6.8B
Holdings
124
Report Date
Q4 2021
Filing Type
13F-HR
All Holdings (124 positions)
| Stock | Value |
|---|---|
SPYSPDR S&P 500 ETF TR | $422.6M |
RCKTROCKET PHARMACEUTICALS INC | $345.0M |
ALNYALNYLAM PHARMACEUTICALS INC | $335.1M |
TMOTHERMO FISHER SCIENTIFIC INC | $290.6M |
3M4MASIMO CORP | $248.9M |
MRTXEURMIRATI THERAPEUTICS INC | $229.1M |
PTCTPTC THERAPEUTICS INC | $210.9M |
ILMNILLUMINA INC | $186.6M |
PENPENUMBRA INC | $178.4M |
VCELVERICEL CORP | $177.5M |
TNDMTANDEM DIABETES CARE INC | $174.7M |
NTRANATERA INC | $173.9M |
ESTAESTABLISHMENT LABS HLDGS INC | $156.8M |
TCE2CELLDEX THERAPEUTICS INC NEW | $151.5M |
—PROMETHEUS BIOSCIENCES INC | $129.1M |
GMEDGLOBUS MED INC | $120.6M |
CYTKCYTOKINETICS INC | $116.7M |
RAREULTRAGENYX PHARMACEUTICAL IN | $115.5M |
RNAAVIDITY BIOSCIENCES INC | $114.0M |
OPHTEURIVERIC BIO INC | $112.4M |
ARGXARGENX SE | $111.2M |
5E7ITEOS THERAPEUTICS INC | $109.6M |
TXG10X GENOMICS INC | $109.4M |
AXNX*AXONICS INC | $108.9M |
APLSAPELLIS PHARMACEUTICALS INC | $94.1M |
PTGXPROTAGONIST THERAPEUTICS INC | $88.9M |
STOKSTOKE THERAPEUTICS INC | $87.4M |
GHGUARDANT HEALTH INC | $81.3M |
CCCCC4 THERAPEUTICS INC | $80.3M |
PMVPPMV PHARMACEUTICALS INC | $68.9M |
FULCFULCRUM THERAPEUTICS INC | $68.4M |
MGNXMACROGENICS INC | $63.8M |
AXSMAXSOME THERAPEUTICS INC | $61.2M |
RGNXREGENXBIO INC | $60.3M |
IDYAIDEAYA BIOSCIENCES INC | $59.6M |
CUTREURCUTERA INC | $57.7M |
PRQRPROQR THRAPEUTICS N V | $56.3M |
BCYCBICYCLE THERAPEUTICS PLC | $52.9M |
TORCEURADICET BIO INC | $52.9M |
SRPTSAREPTA THERAPEUTICS INC | $52.4M |
GHRSGH RESEARCH PLC | $50.6M |
—SCIENCE 37 HOLDINGS INC | $49.6M |
DMTKQDERMTECH INC | $49.3M |
RLMDRELMADA THERAPEUTICS INC | $49.3M |
BLUBELLUS HEALTH INC NEW | $48.0M |
TNYATENAYA THERAPEUTICS INC | $46.6M |
AVDLAVADEL PHARMACEUTICALS PLC | $46.4M |
TARSTARSUS PHARMACEUTICALS INC | $45.3M |
APYXAPYX MEDICAL CORPORATION | $43.6M |
IMCRIMMUNOCORE HLDGS PLC | $42.6M |
OMGBPOUTSET MED INC | $41.2M |
OYSTOYSTER PT PHARMA INC | $37.6M |
EPIEURESSA PHARMA INC | $37.4M |
LUNGPULMONX CORP | $37.3M |
VTYXVENTYX BIOSCIENCES INC | $30.8M |
QTRXQUANTERIX CORP | $29.1M |
MISTMILESTONE PHARMACEUTICALS IN | $28.3M |
CTMXCYTOMX THERAPEUTICS INC | $26.1M |
CSTLCASTLE BIOSCIENCES INC | $25.7M |
NSTGEURNANOSTRING TECHNOLOGIES INC | $25.5M |
—ATHIRA PHARMA INC | $24.8M |
GLUEMONTE ROSA THERAPEUTICS INC | $24.8M |
JNCEEURJOUNCE THERAPEUTICS INC | $23.9M |
PYXSPYXIS ONCOLOGY INC | $23.3M |
ARWRARROWHEAD PHARMACEUTICALS IN | $23.0M |
CERE1EURCEREVEL THERAPEUTICS HLDNG I | $21.6M |
JNJJOHNSON & JOHNSON | $21.4M |
SGHTSIGHT SCIENCES INC | $20.8M |
—LANDOS BIOPHARMA INC | $20.5M |
—RENOVACOR INC | $20.4M |
AGENEURAGENUS INC | $18.9M |
—OLINK HLDG AB | $18.5M |
WHWKAADI BIOSCIENCES INC | $18.5M |
TELATELA BIO INC | $17.9M |
IMUXIMMUNIC INC | $16.4M |
ADVMCHFADVERUM BIOTECHNOLOGIES INC | $13.3M |
BWAYBRAINSWAY LTD | $12.3M |
—LA JOLLA PHARMACEUTICAL CO | $10.8M |
NEONEOGENOMICS INC | $10.6M |
CLSDUSDCLEARSIDE BIOMEDICAL INC | $10.5M |
EP3ORASURE TECHNOLOGIES INC | $10.0M |
I9DNARBUTUS BIOPHARMA CORP | $9.7M |
XGNEXAGEN INC | $9.6M |
—GENETRON HLDGS LTD | $8.7M |
URGNUROGEN PHARMA LTD | $8.2M |
ROIVROIVANT SCIENCES LTD | $8.1M |
NYXHNYXOAH S A | $7.9M |
—VINCERX PHARMA INC | $7.6M |
MRUSMERUS N V | $6.2M |
—RESEARCH ALLIANCE CORP II | $6.2M |
—BCLS ACQUISITION CORP | $6.0M |
NAUTNAUTILUS BIOTECHNOLOGY INC | $5.7M |
—SUMMIT HEALTHCRE ACQUISTN CO | $5.0M |
—ARYA SCIENCES ACQU CORP IV | $5.0M |
PRCTPROCEPT BIOROBOTICS CORP | $4.9M |
—ARYA SCIENCES ACQUISITN CORP | $4.8M |
IMTXIMMATICS N.V | $4.7M |
BMEABIOMEA FUSION INC | $4.4M |
SOPHSOPHIA GENETICS SA | $4.2M |
—5 01 ACQUISITION CORP | $3.9M |
Page 1 of 2Next